121 related articles for article (PubMed ID: 2359016)
1. Electrophysiologic effects of E-4031, a class III antiarrhythmic agent, on re-entrant ventricular arrhythmias in a canine 7-day-old myocardial infarction model.
Katoh H; Ogawa S; Furuno I; Sato Y; Yoh S; Saeki K; Nakamura Y
J Pharmacol Exp Ther; 1990 Jun; 253(3):1077-82. PubMed ID: 2359016
[TBL] [Abstract][Full Text] [Related]
2. Antiarrhythmic efficacy of a new class III agent, UK-68,798, during chronic myocardial infarction: evaluation using three-dimensional mapping.
Zuanetti G; Corr PB
J Pharmacol Exp Ther; 1991 Jan; 256(1):325-34. PubMed ID: 1988663
[TBL] [Abstract][Full Text] [Related]
3. Epicardial, endocardial and transmural mapping in assessing electrophysiological effects of 14-C lidocaine and 14-C propafenone on activation times in experimental chronic myocardial infarction. Correlations with myocardial drugs concentrations.
Naccarella FF; Agarwal JB; Weintraub WS; Bracchetti D; Helfant RH
G Ital Cardiol; 1984 Oct; 14(10):825-9. PubMed ID: 6519392
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiological effects of flecainide in a canine 7 day old myocardial infarction model.
Sakai T; Ogawa S; Hosokawa M; Miyazaki T; Sakurai K; Nakamura Y
Cardiovasc Res; 1989 Mar; 23(3):177-83. PubMed ID: 2512008
[TBL] [Abstract][Full Text] [Related]
5. Effects of pirmenol on electrical induction of sustained ventricular tachycardia in a seven-day-old canine myocardial infarction.
Nitta J; Nogami A; Aonuma K; Akimoto H; Chung YH; Takahashi A; Iesaka Y; Marumo F; Hiraoka M
J Cardiovasc Pharmacol; 1991 Jan; 17(1):54-60. PubMed ID: 1708056
[TBL] [Abstract][Full Text] [Related]
6. Suppression of lethal ischemic ventricular arrhythmias by the class III agent E4031 in a canine model of previous myocardial infarction.
Lynch JJ; Heaney LA; Wallace AA; Gehret JR; Selnick HG; Stein RB
J Cardiovasc Pharmacol; 1990 May; 15(5):764-75. PubMed ID: 1692937
[TBL] [Abstract][Full Text] [Related]
7. Antiarrhythmic and electrophysiologic effects of bepridil in chronically infarcted conscious dogs.
Lynch JJ; Montgomery DG; Ventura A; Lucchesi BR
J Pharmacol Exp Ther; 1985 Jul; 234(1):72-80. PubMed ID: 3874285
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiologic properties of the myocardial infarction border zone: effects of transient aortic occlusion.
Tobler HG; Gornick CC; Anderson RW; Benditt DG
Surgery; 1986 Aug; 100(2):150-6. PubMed ID: 2426817
[TBL] [Abstract][Full Text] [Related]
9. Effects of SUN-1165, N-(2,6-dimethylphenyl)-8-pyrrolizidine acetamide hydrochloride hemihydrate, a new class I antiarrhythmic drug, on ventricular arrhythmias, intraventricular conduction, and the refractory period in canine myocardial infarction.
Hashimoto H; Satoh N; Nakashima M
J Cardiovasc Pharmacol; 1992 Mar; 19(3):417-24. PubMed ID: 1378123
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiologic actions of clofilium and lidocaine in ischemically injured canine epicardium.
Patterson E; Scherlag BJ; Lazzara R
J Pharmacol Exp Ther; 1992 Jul; 262(1):375-82. PubMed ID: 1625209
[TBL] [Abstract][Full Text] [Related]
11. Iontophoretic transmyocardial drug delivery. A novel approach to antiarrhythmic drug therapy.
Avitall B; Hare J; Zander G; Bockoff C; Tchou P; Jazayeri M; Akhtar M
Circulation; 1992 Apr; 85(4):1582-93. PubMed ID: 1555296
[TBL] [Abstract][Full Text] [Related]
12. Differing electrophysiologic effects of slow response inhibiting agents manganese and verapamil on ischemic, infarcted and normal tissue in situ.
Kupersmith J; Cohen R
J Pharmacol Exp Ther; 1980 Nov; 215(2):394-400. PubMed ID: 7441504
[TBL] [Abstract][Full Text] [Related]
13. Antiarrhythmic effects of desethylamiodarone in dogs with subacute myocardial infarction and inducible ventricular arrhythmias.
Abdollah H; Brien JF; Brennan FJ
J Cardiovasc Pharmacol; 1989 Jan; 13(1):37-44. PubMed ID: 2468934
[TBL] [Abstract][Full Text] [Related]
14. [Electrophysiological effects of berbamine on ischemic ventricular tachyarrhythmia].
Guo ZB; Cao HY; Xu Z; Li Q
Zhongguo Yao Li Xue Bao; 1991 Jan; 12(1):44-7. PubMed ID: 1950584
[TBL] [Abstract][Full Text] [Related]
15. Effects of class I drugs on reentrant ventricular tachycardia in a canine model of myocardial infarction: on their antiarrhythmic and proarrhythmic mechanisms.
Miyazaki T; Ogawa S; Sakai T; Hosokawa M; Sakurai K; Nakamura Y
Jpn Circ J; 1988 Mar; 52(3):254-61. PubMed ID: 3373717
[TBL] [Abstract][Full Text] [Related]
16. Antiarrhythmic drugs preferentially produce conduction block at the area of slow conduction in the re-entrant circuit of canine atrial flutter: comparative study of disopyramide, flecainide, and E-4031.
Inoue H; Yamashita T; Usui M; Nozaki A; Sugimoto T
Cardiovasc Res; 1991 Mar; 25(3):223-9. PubMed ID: 1903082
[TBL] [Abstract][Full Text] [Related]
17. Effects of DPI 201-106, a novel cardiotonic agent, on hemodynamics, cardiac electrophysiology and arrhythmias induced by programmed ventricular stimulation in dogs with subacute myocardial infarction: a comparative study with dobutamine.
Ozaki T; Uematsu T; Nagashima S; Nishimoto M; Nakashima M
Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):478-87. PubMed ID: 1766473
[TBL] [Abstract][Full Text] [Related]
18. Antiarrhythmic and electrophysiologic effects of MDL 11,939, a novel class III antiarrhythmic agent in anesthetized dogs.
Koerner JE; Dage RC
J Cardiovasc Pharmacol; 1990 Sep; 16(3):383-93. PubMed ID: 1700208
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiology and antiarrhythmic actions of E-4031 in the experimental animal model of sudden coronary death.
Chi LG; Mu DX; Lucchesi BR
J Cardiovasc Pharmacol; 1991 Feb; 17(2):285-95. PubMed ID: 1709234
[TBL] [Abstract][Full Text] [Related]
20. Failure of lidocaine to suppress lethal ischemic ventricular arrhythmias in a canine model of previous myocardial infarction.
Lynch JJ; Heaney LA; Wallace AA; Gehret JR; Stein RB
J Cardiovasc Pharmacol; 1990 Jul; 16(1):41-9. PubMed ID: 1696665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
